Archive for July 2026

US Unfair Trade Investigation: German Pharmaceutical Pricing

Client Update | July 2026 Executive Summary The United States Trade Representative (USTR) has initiated a Section 301 unfair trade investigation into German pharmaceutical pricing practices. This presents significant implications for manufacturers, healthcare authorities, and policymakers. The law is commonly used to impose import tariffs, although no specific remedy has yet been detailed. Stakeholders are […]